Progression of carcinoma cells is associated with alterations in chromatin structure and factor binding at the E-cadherin promoter in vivo.
about
RB and c-Myc activate expression of the E-cadherin gene in epithelial cells through interaction with transcription factor AP-2.Nuclear speckle-associated protein Pnn/DRS binds to the transcriptional corepressor CtBP and relieves CtBP-mediated repression of the E-cadherin geneAutoregulation of E-cadherin expression by cadherin-cadherin interactions: the roles of beta-catenin signaling, Slug, and MAPKE-cadherin roles in animal biology: A perspective on thyroid hormone-influenceMolecular interaction map of the mammalian cell cycle control and DNA repair systems.Epigenetic gene silencing in cancer.Epithelial mesenchymal transition by c-Fos estrogen receptor activation involves nuclear translocation of beta-catenin and upregulation of beta-catenin/lymphoid enhancer binding factor-1 transcriptional activity.Snail family regulation and epithelial mesenchymal transitions in breast cancer progressionHeterogeneity in the modification and involvement of chromatin components of the CpG island of the silenced human CDH1 gene in cancer cells.CDH1 germline mutation in hereditary gastric carcinoma.Snail2 is an essential mediator of Twist1-induced epithelial mesenchymal transition and metastasisFibroblast growth factor 2 induces E-cadherin down-regulation via PI3K/Akt/mTOR and MAPK/ERK signaling in ovarian cancer cellsTarget genes of beta-catenin-T cell-factor/lymphoid-enhancer-factor signaling in human colorectal carcinomas.Expression of transcription factor AP-2 in colorectal adenomas and adenocarcinomas; comparison of immunohistochemistry and in situ hybridisation.E-cadherin gene mutations frequently occur in synovial sarcoma as a determinant of histological features.Epithelial-mesenchymal transition in cervical carcinoma.Expression of E-cadherin and other paracellular junction genes is decreased in iron-loaded hepatocytesInactivation of the E-cadherin-mediated cell adhesion system in human cancers.Suppression of invasion and metastasis of triple-negative breast cancer lines by pharmacological or genetic inhibition of slug activity.Sp1 binding plays a critical role in Erb-B2- and v-ras-mediated downregulation of alpha2-integrin expression in human mammary epithelial cells.DNA methylation analysis at distal and proximal promoter regions of the oestrogen receptor gene in breast cancers.Epithelial morphological reversion drives Profilin-1-induced elevation of p27(kip1) in mesenchymal triple-negative human breast cancer cells through AMP-activated protein kinase activation.Grhl3 induces human epithelial tumor cell migration and invasion via downregulation of E-cadherinBypassing cellular EGF receptor dependence through epithelial-to-mesenchymal-like transitionsEpithelial-mesenchymal transition mediated tumourigenesis in the gastrointestinal tract.Absence of germline mono-allelic promoter hypermethylation of the CDH1 gene in gastric cancer patients.Profilin-1 overexpression restores adherens junctions in MDA-MB-231 breast cancer cells in R-cadherin-dependent manner.Interplay of cadherin-mediated cell adhesion and canonical Wnt signaling.Prostate tumor cell plasticity: a consequence of the microenvironment.Butyrate down-regulates CD44 transcription and liver colonisation in a highly metastatic human colon carcinoma cell line.Identification and optimization of small molecules that restore E-cadherin expression and reduce invasion in colorectal carcinoma cells.Ligand activation of the androgen receptor downregulates E-cadherin-mediated cell adhesion and promotes apoptosis of prostatic cancer cellsButyrate regulates E-cadherin transcription, isoform expression and intracellular position in colon cancer cells.Inhibiting interactions of lysine demethylase LSD1 with snail/slug blocks cancer cell invasionAllele loss, replication errors and loss of expression of E-cadherin in colorectal cancersNicotinic Acetylcholine Receptor Subtype Alpha-9 Mediates Triple-Negative Breast Cancers Based on a Spontaneous Pulmonary Metastasis Mouse Model.
P2860
Q24522518-274A61B2-C95A-47DE-B3C0-4C40C4738A6AQ24559995-EF871966-6654-4236-97FD-D733448558E0Q24672084-67BA7389-5A5E-44DC-BD29-041005BEC627Q28079585-A7A7E63F-65BD-4093-AEB5-C74E51042E1FQ33704559-1963FED5-46AC-401D-84D7-6AAC717C8B69Q33843160-1567558C-D718-47EC-8DB6-017D9F9AF41DQ33886142-520F929B-3CCC-4050-9F1C-8E151FC1A2A8Q34095480-527EA2ED-E2FC-457E-B382-6FF2F83AB54BQ34329052-78ED0384-523D-49D4-90DA-7AAEB0A74EEDQ34354504-2F8DC17C-AD6B-4C79-BB4F-7C8932A9A3C8Q34515040-D0C9F1F2-15D7-40E4-92F6-2F716DA79FEAQ34648726-47CF5ECD-5C51-45C7-861C-F42855F287EAQ35004950-2790493C-6613-4D47-9323-49B5FB625C27Q35399244-4E009CF8-CFBF-4290-8FA0-31A7B85FA783Q35747099-D19F4484-56CB-4250-9876-361736490F3CQ35747467-242E02FB-2BF1-4BA6-8224-0ABC49836E7EQ35749206-E1F1D798-58F9-40D7-8C9E-E32A8145C658Q35753235-20716BD5-4E38-4223-944D-0612B1A1B4DFQ36018843-E332B6DF-0AAD-4908-A4AC-72C6F693D861Q36563516-9BFBFCDB-7EB6-4351-A77C-B09578890670Q36640883-840F88C5-99B4-4FDB-B424-60667EB87131Q36780655-5537BBA8-46BB-4B93-9D53-F0104985D051Q36947136-F33BB74E-6810-4EB1-9BB3-E1D208131376Q37072581-4FA905CC-B33E-4357-BE75-CE1A60F73700Q37210185-C9E94CCD-1E48-4A0F-A88E-2286AA9473C1Q37318009-66DA89BF-4E6F-4633-9657-448769C3F180Q37440140-11E56515-0017-48C0-B122-A42FDAF8AD3AQ37698281-CDA78AB4-BC59-4281-A2C3-1696645AEEFAQ37929041-AAE55C0A-95AE-48D2-9571-A8E3C58E1EF4Q38360807-0B8AEF46-787E-4F8A-8308-8467D52098F6Q39606987-09D4EF98-A315-4D0B-8B4D-B72F618399F4Q40631293-DC0C86A1-2999-4104-9701-06008BAFDF82Q40905894-2464FD93-24D8-4249-BB56-E0D9A57CC08FQ42534955-5D7D1682-0A71-49EE-BCD9-CB58621A71F3Q42581092-EA099949-E1A9-465D-90DC-679177CC5394Q47116263-A46EE07E-878C-48CA-8051-1933EE43FEC3
P2860
Progression of carcinoma cells is associated with alterations in chromatin structure and factor binding at the E-cadherin promoter in vivo.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年学术文章
@wuu
1995年学术文章
@zh-cn
1995年学术文章
@zh-hans
1995年学术文章
@zh-my
1995年学术文章
@zh-sg
1995年學術文章
@yue
1995年學術文章
@zh
1995年學術文章
@zh-hant
name
Progression of carcinoma cells ...... e E-cadherin promoter in vivo.
@en
type
label
Progression of carcinoma cells ...... e E-cadherin promoter in vivo.
@en
prefLabel
Progression of carcinoma cells ...... e E-cadherin promoter in vivo.
@en
P2093
P1433
P1476
Progression of carcinoma cells ...... he E-cadherin promoter in vivo
@en
P2093
P304
P407
P577
1995-08-01T00:00:00Z